CSNews

Philip Morris International Requests Continued Modified-Risk Claim for IQOS

SILVER SPRING, Md. — Philip Morris International Inc. (PMI) made its case to continue to market its heat-not-burn IQOS as a ...

Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product

The FDA granted the MRTP designation to the IQOS system in 2020 for an initial four-year period. The evidence presented to TPSAC was a necessary step to obtain MRTP designation for Philip Morris’ ( ...
Agence France-Presse

Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific ...
Morningstar

PMI Moves Closer to U.S. iQOS Distribution As It Ditches Altria and Raises Offer for Swedish Match

Altria, the leading U.S. cigarette manufacturer, and Philip Morris International have reached an agreement under which Altria will forgo the exclusive rights to commercialize iQOS, PMI's heated ...